000			01375 a2200373 4500
005			20250511151847.0
264		0	_c19770331
008			197703s 0 0 eng d
022			_a0361-5960
040			_aNLM _beng _cNLM
100	1		_aPanettiere, F J
245	0	0	_aPorfiromycin in the management of epidermoid and transitional cell cancer: a phase II study. _h[electronic resource]
260			_bCancer treatment reports _cJul 1976
300			_a907-11 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aCarcinoma, Transitional Cell _xdrug therapy
650	0	4	_aClinical Trials as Topic
650	0	4	_aFemale
650	0	4	_aHead and Neck Neoplasms _xdrug therapy
650	0	4	_aHumans
650	0	4	_aLeukopenia _xchemically induced
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aPorfiromycin _xadverse effects
650	0	4	_aThrombocytopenia _xchemically induced
650	0	4	_aUreteral Neoplasms _xdrug therapy
650	0	4	_aUrinary Bladder Neoplasms _xdrug therapy
650	0	4	_aUterine Cervical Neoplasms _xdrug therapy
650	0	4	_aVulvar Neoplasms _xdrug therapy
700	1		_aTalley, R W
700	1		_aTorres, J
700	1		_aLane, M
773	0		_tCancer treatment reports _gvol. 60 _gno. 7 _gp. 907-11
999			_c806074 _d806074